Abstract
Objective
To investigate mortality among nuclear workers with potential internal exposure to uranium.
Methods
The cohort included 2,709 workers employed at the AREVA NC Pierrelatte plant for at least 6 months (72,787 person-years). This plant processed uranium enrichment during the period 1960–1996 and chemical conversion since 1980. Mortality was compared to the national and regional mortality rates available for the period 1968–2005. For causes of death of interest with respect to occupational exposure, mortality trends according to occupational characteristics were assessed.
Results
As expected, an important healthy worker effect (all causes SMR = 0.55 (95% CI: 0.50–0.61), n = 411; all cancers SMR = 0.70 (95% CI: 0.60–0.81), n = 193) was observed. Among cancer sites a priori related to uranium exposure, only mortality for lymphatic cancer was increased among potentially exposed workers (SMR = 1.49 (95% CI: 0.68–2.82); n = 9). An important increase in mortality from pleural cancer was observed (SMR = 2.85 (95% CI: 0.93–6.66), n = 5); none of the deceased workers were exposed to radiation whereas all handled asbestos.
Conclusion
In spite of limited statistical power, results show consistency with previous studies of nuclear workers potentially exposed to uranium. Further investigation based on more precise uranium exposure data should allow the estimation of uranium hazard effects among this cohort.
Similar content being viewed by others
References
Atkinson WD, Law DV, Bromley KJ, Inskip HM (2004) Mortality of employees of the United Kingdom Atomic Energy Authority, 1946–97. Occup Environ Med 61(7):577–585
Baas P, Schouwink H, Zoetmulder FA (1998) Malignant pleural mesothelioma. Ann Oncol 9(2):139–149
Baysson H, Laurier D, Tirmarche M, Valenty M, Giraud JM (2000) Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occup Environ Med 57(3):188–194
Boice JD, Cohen SS, Mumma MT, Dupree Ellis EA, Eckerman KF, Leggett RW et al (2006) Mortality among radiation workers at Rocketdyne (Atomic International), 1948–1999. Radiat Res 165:98–115
Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume II—the design and analysis of cohort studies. IARC Scientific, Lyon
Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK et al (1995) Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 142(2):117–132
Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C et al (2005) Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. Br Med J 331(7508):77–80
Cardis E, Vrijheid M, Blettner M, Gilbert E, Hakama M, Hill C et al (2007) The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 167(4):396–416
Carpenter LM, Higgins C, Douglas A, Fraser P, Beral V, Smith P (1994) Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946–1988. Radiat Res 138(2):224–238
Carpenter LM, Higgins CD, Douglas AJ, Maconochie NE, Omar RZ, Fraser P et al (1998) Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. Br J Cancer 78(9):1224–1232
Checkoway H, Pearce N, Crawford-Brown DJ, Cragle DL (1988) Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol 127(2):255–266
Dupree-Ellis E, Watkins J, Ingle JN, Phillips J (2000) External radiation exposure and mortality in a cohort of uranium processing workers. Am J Epidemiol 152(1):91–95
Galle P, Berry JP, Galle C (1992) Role of alveolar macrophages in precipitation of mineral elements inhaled as soluble aerosols. Environ Health Perspect 97:145–147
Guseva Canu I, Ellis ED, Tirmarche M (2008a) Cancer risk in nuclear workers occupationally exposed to uranium-emphasis on internal exposure. Health Phys 94(1):1–17
Guseva Canu I, Molina G, Goldberg M, Collomb P, David JC, Perez P et al (2008b) Development of a job exposure matrix for the epidemiological follow-up of workers in the French nuclear industry. Rev Epidemiol Sante Publique 56(1):21–29
Guseva Canu I, Paquet F, Goldberg M, Auriol B, Berard P, Collomb P et al. 2008c. Comparative assessing for radiological, chemical, and physical exposures at the French uranium conversion plant: Is uranium the only stressor? Int J Hyg Environ Health. doi:10.1016/j.ijheh.2008.09.002
Hill JK, Heitmiller RFII, Askin FB, Kuhlman JE (1997) Localized benign pleural mesothelioma arising in a radiation field. Clin Imaging 21(3):189–194
Huncharek M (2002) Non-asbestos related diffuse malignant mesothelioma. Tumori 88(1):1–9
Kathren RL, McInroy JF, Moore RH, Dietert SE (1989) Uranium in the tissues of an occupationally exposed individual. Health Phys 57(1):17–21
Kawashima A, Libshitz HI, Lukeman JM (1990) Radiation-induced malignant pleural mesothelioma. Can Assoc Radiol J 41(6):384–386
Keane AT, Polednak AP (1983) Retention of uranium in the chest: implications of findings in vivo and postmortem. Health Phys 44(Suppl 1):391–402
Kyle RA, Rajkumar SV (2007) Epidemiology of the plasma-cell disorders. Best Prac Res Clin Haematol 20(4):637–664
Leach LJ, Yuile CL, Hodge HC (1973) A five year inhalation study with natural uranium dioxide (UO2) dust. II. Postexposure retention and biologic effects in the monkey, dog and rat. Health Phys 25(3):239–258
Lerman Y, Learman Y, Schachter P, Herceg E, Lieberman Y, Yellin A (1991) Radiation associated malignant pleural mesothelioma. Thorax 46(6):463–464
Loomis DP, Wolf SH (1996) Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947–1990. Am J Ind Med 29(2):131–141
McGeoghegan D, Binks K (2000) The mortality and cancer morbidity experience of workers at the Capenhurst uranium enrichment facility 1946–95. J Radiol Prot 20(4):381–401
McGeoghegan D, Binks K, Gillies M, Jones S, Whaley S (2008) The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946–2005. Int J Epidemiol 37(3):506–518
Metz-Flamant C, Rogel A, Caer S, Samson E, Laurier D, Acker A et al. (in press). [EPICOH] mortality among workers monitored for radiation exposure at the French nuclear fuel company. Arch Environ Occup Health
Morgenstern H, Ritz B (2001) Effects of radiation and chemical exposures on cancer mortality among Rocketdyne workers: a review of three cohort studies. Occup Med 16(2):219–237
Muirhead CR, O’Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL et al (2009) Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer 100(1):206–212
Pinkerton LE, Bloom TF, Hein MJ, Ward EM (2004) Mortality among a cohort of uranium mill workers: an update. Occup Environ Med 61(1):57–64
Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F et al (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 51(1 Pt 1):3–30
Ritz B (1999a) Cancer mortality among workers exposed to chemicals during uranium processing. J Occup Environ Med 41(7):556–566
Ritz B (1999b) Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10(5):531–538
Ritz B, Morgenstern H, Crawford-Brown D, Young B (2000) The effects of internal radiation exposure on cancer mortality in nuclear workers at Rocketdyne/Atomics International. Environ Health Perspect 108(8):743–751
Rogel A, Carre N, Amoros E, Bonnet-Belfais M, Goldberg M, Imbernon E et al (2005) Mortality of workers exposed to ionizing radiation at the French National Electricity Company. Am J Ind Med 47(1):72–82
Russell JJ, Kathren RL (2004) Uranium deposition and retention in a USTUR whole body case. Health Phys 86(3):273–284
Shannon VR, Nesbitt JC, Libshitz HI (1995) Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients. Cancer 76(3):437–441
Telle-Lamberton M, Bergot D, Gagneau M, Samson E, Giraud JM, Neron MO et al (2004) Cancer mortality among French Atomic Energy Commission workers. Am J Ind Med 45(1):34–44
Telle-Lamberton M, Samson E, Caer S, Bergot D, Bard D, Bermann F et al (2007) External radiation exposure and mortality in a cohort of French nuclear workers. Occup Environ Med 64(10):694–700
Teta MJ, Lau E, Sceurman BK, Wagner ME (2007) Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer 109(7):1432–1438
UNSCEAR (2000) Sources and effects of ionizing radiation United Nations, New York. United Nations, NY, USA
Valenty M, Tirmarche M, Mitton N, Laurier D, Gelas JM, Quesne B (2003) Causes of death of COGEMA active workers, 1980–1995. Rev Epidemiol Sante Publique 51(5):461–468
Weiner SJ, Neragi-Miandoab S (2008) Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Carcinog 7:3
Weissmann LB, Corson JM, Neugut AI, Antman KH (1996) Malignant mesothelioma following treatment for Hodgkin’s disease. J Clin Oncol 14(7):2098–2100
Yang H, Testa JR, Carbone M (2008) Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 9(2–3):147–157
Acknowledgments
The authors gratefully acknowledge the help of Mr Régis Colin from the INRS in gathering regional statistics. This work was performed as a part of a Ph.D. graduate study financially supported by IRSN and AREVA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guseva Canu, I., Cardis, E., Metz-Flamant, C. et al. French cohort of the uranium processing workers: mortality pattern after 30-year follow-up. Int Arch Occup Environ Health 83, 301–308 (2010). https://doi.org/10.1007/s00420-009-0455-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00420-009-0455-0